Radioiodine therapy for hyperthyroidism

Drug and Therapeutics Bulletin

Volumn 44, Issue 6, 2006, Pages 44-48

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; CARBIMAZOLE; CORTICOSTEROID; IODINE 131; LEVOTHYROXINE; PREDNISOLONE; PROPYLTHIOURACIL; RADIOACTIVE IODINE;

AGRANULOCYTOSIS; ARTICLE; BODY WEIGHT DISORDER; CLINICAL PROTOCOL; CLINICAL TRIAL; DISEASE SEVERITY; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG ERUPTION; DRUG MECHANISM; DRUG USE; EYE DISEASE; FOLLOW UP; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; QUALITY OF LIFE; RADIATION EXPOSURE; SUBTOTAL THYROIDECTOMY; THYROID ADENOMA; THYROID CANCER; THYROIDITIS; TOXIC GOITER; TREATMENT OUTCOME; WEIGHT GAIN;

ADULT; ANTITHYROID AGENTS; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; RADIATION INJURIES;

EID: 33745648774     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.2006.44644     Document Type: Article

References (46)

1. Radioiodine for the treatment of thyroid disease. DTB 1993; 31: 39-40.
2. Hart D, Wall BF. A survey of nuclear medicine in the UK in 2003/4. Health Protection Agency, 2005 [online]. Available: http://www.hpa.org.uk/radiation/publications/hpa_rpd_reports/2005/ hpa_rpd_003.htm [Accessed 4 May 2006].
3. Tunbridge WMG et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977; 7: 481-93.
4. Dorr M, Völzke H. Cardiovascular morbidity and mortality in thyroid dysfunction. Minerva Endocrinol 2005; 30: 199-216.
5. Franklyn JA. The management of hyperthyroidism. N Engl J Med 1994; 330: 1731-8.
6. Wiersinga WM, Bartalena L. Epidemiology and prevention of Graves' ophthalmopathy. Thyroid 2002; 12: 855-60.
7. Hermus AR, Huysmans DA. Treatment of benign nodular thyroid disease. N Engl J Med 1998; 338: 1438-47.
8. Department of Health, 2005. The Administration of Radioactive Substances Advisory Committee (ARSAC) [online]. Available: http://www.advisorybodies.doh.gov.uk/arsac/index.htm [Accessed 2 May 2006].
9. European Commission. Radiation protection 97. Radiation protection following iodine-131 therapy (exposures due to out-patients or discharged in-patients). Luxembourg, Belgium; Office for Official Publications of the European Communities, 1998 [online]. Available: http://europa.eu.int/comm/energy/nuclear/radioprotection/publication/ doc/097_en.pdf [Accessed 2 May 2006].
10. 131iodine activity. Results from a prospective, randomized, multicentre study. Eur J Clin Invest 1995; 25: 186-93.
11. Jarløv AE et al. Is calculation of the dose in radioiodine therapy of hyperthyroidism worthwhile? Clin Endocrinol 1995; 43: 325-9.
12. Leslie WD et al. A randomized comparison of radioiodine doses in Graves' hyperthyroidism. J Clin Endocrinol Metab 2003; 88: 978-83.
13. Allahabadia A et al. Radioiodine treatment of hyperthyroidism - prognostic factors for outcome. J Clin Endocrinol Metab 2001; 86: 3611-7.
14. 131I, for the treatment of Graves' disease resistant to antithyroid drugs. Hell J Nucl Med 2005; 8: 158-61.
15. Metso S et al. Long-term follow-up study of radioiodine treatment of hyperthyroidism. Clin Endocrinol (Oxf) 2004; 61: 641-8.
16. Peters H et al. Treatment of Graves' hyperthyroidism with radioiodine: results of a prospective randomized study. Thyroid 1997; 7: 247-51.
17. Franklyn JA et al. Long-term follow-up of treatment of thyrotoxicosis by three different methods. Clin Endocrinol (Oxf) 1991; 34: 71-6.
18. Franklyn JA et al. Thyroid function and mortality in patients treated for hyperthyroidism. JAMA 2005; 294: 71-80.
19. Kendall-Taylor P et al. Ablative radioiodine therapy for hyperthyroidism: longterm follow up study. BMJ (Clin Res Ed) 1984; 289: 361-3.
20. Ceccarelli C et al. Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years' retrospective study. Clin Endocrinol (Oxf) 2005; 62: 331-5.
21. Sabri O et al. Success rate of radioiodine therapy in Graves' disease: the influence of thyrostatic medication. J Clin Endocrinol Metab 1999; 84: 1229-33.
22. 131I therapy of hyperthyroid diseases: effect on cure rate evaluated by a randomized clinical trial. J Clin Endocrinol Metab 2004; 89: 4439-44.
23. Evans PM et al. Radioiodine treatment in unsuspected pregnancy. Clin Endocrinol (Oxf) 1998; 48: 281-3.
24. Administration of Radioactive Substances Advisory Committee. Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactve sources. January 2006 [online]. Available: http://www.arsac.org.uk/notes_for_guidence/docs/arsac_nfg.pdf [Accessed 4 May 2006].
25. Rivkees SA et al. The management of Graves' disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab 1998; 83: 3767-76.
26. Read CH et al. A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patients. J Clin Endocrinol Metab 2004; 89: 4229-33.
27. - symporter (NIS): imaging and therapeutic applications. Semin Nucl Med 2004; 34: 23-31.
28. Bartalena L et al. Relationship between management of hyperthyroidism and course of the ophthalmopathy. J Endocrinol Invest 2004; 27: 288-94.
29. Tallstedt L et al. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. N Engl J Med 1992; 326: 1733-8.
30. Royal College of Physicians of London. Guidelines: The use of radioiodine in the management of benign thyroid disorders. 2006 [in preparation].
31. Perros P et al. A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active Graves' ophthalmopathy. J Clin Endocrinol Metab 2005; 90: 5321-3.
32. Bartalena L et al. Relation between therapy for hyperthyroidism and course of Graves' ophthalmopathy. N Engl J Med 1998; 338: 73-8.
33. McDermott MT et al. Radioiodine-induced thyroid storm. Case report and literature review. Am J Med 1983; 75: 353-9.
34. Dale J et al. Weight gain following treatment of hyperthyroidism. Clin Endocrinol (Oxf) 2001; 55: 233-9.
35. Ron E et al. Cancer mortality following treatment for adult hyperthyroidism. JAMA 1998; 280: 347-55.
36. Franklyn JA et al. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet 1999; 353: 2111-5.
37. Institute of Physics and Engineering in Medicine. Medical and Dental Guidance Notes. A good practice guide on all aspects of ionising radiation protection in the clinical environment. York: IPEM, 2002.
38. Abraham P et al. Antithyroid drug regimen for treating Graves' hyperthyroidism. The Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD003420.pub3.
39. Pearce SHS. Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK. Clin Endcrinol (Oxf) 2004; 61: 589-4.
40. Marcocci C et al. The course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: a case-control study. Clin Endocrinol (Oxf) 1999; 51: 503-8.
41. Ku CF et al. Total thyroidectomy replaces subtotal thyroidectomy as the preferred surgical treatment for Graves' disease. ANZ J Surg 2005; 75: 528-31.
42. Werga-Kjellman P et al. Surgical treatment of hyperthyroidism: a ten-year experience. Thyroid 2001; 11: 187-92.
43. Prades JM et al. Multinodular goiter: surgical management and histopathological findings. Eur Arch Otorhinolaryngol 2002; 259: 217-21.
44. Azizi F et al. Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine. Eur J Endocrinol 2005; 152: 695-701.
45. Torring O et al. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine - a prospective, randomized study. J Clin Endocrinol Metab 1996; 81: 2986-93.
46. Abraham-Nordling M et al. Graves' disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, surgery. Thyroid 2005; 15: 1279-86.